NovaBridge Biosciences (FRA:0VY)
Germany · Delayed Price · Currency is EUR 3.260
+0.020 (0.62%)
At close: Nov 28, 2025
NovaBridge Biosciences Market Cap
NovaBridge Biosciences has a market cap or net worth of €380.74 million as of December 2, 2025. Its market cap has increased by 375.42% in one year.
Market Cap
380.74M
Enterprise Value
241.28M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€3.26
Market Cap Chart
Since January 17, 2020, NovaBridge Biosciences's market cap has increased from 124.45M to 380.74M, an increase of 205.94%. That is a compound annual growth rate of 20.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 1, 2025 | 380.74M | 469.47% |
| Dec 31, 2024 | 66.86M | -53.13% |
| Dec 29, 2023 | 142.66M | -56.11% |
| Dec 30, 2022 | 325.02M | -89.87% |
| Dec 31, 2021 | 3.21B | 18.02% |
| Dec 31, 2020 | 2.72B | 2,083.42% |
| Jan 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.88B |
| Siemens Aktiengesellschaft | 176.79B |
| Allianz SE | 141.56B |
| Deutsche Telekom AG | 132.19B |
| Siemens Energy AG | 98.23B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.85B |
| Rheinmetall AG | 67.93B |
| Deutsche Bank Aktiengesellschaft | 58.37B |